Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
04/2005
04/14/2005WO2005033283A2 Methods for enhancing the analysis of particle detection
04/14/2005WO2005033282A2 Polyamide compositions and therapeutic methods for treatment of human papilloma virus
04/14/2005WO2005033281A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
04/14/2005WO2005033280A2 Hiv-dependent expression constructs and uses therefor
04/14/2005WO2005033279A2 Discovery of novel soluble crystalline anesthetics
04/14/2005WO2005033278A2 In vivo efficacy of ny-eso-1 plus iscom
04/14/2005WO2005033277A2 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase
04/14/2005WO2005033275A2 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
04/14/2005WO2005033274A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
04/14/2005WO2005033272A2 In vivo synthesis of connective tissues
04/14/2005WO2005033271A2 METHODS OF RAPID DETECTION AND IDENTIFICATION OF BIOAGENTS USING microRNA
04/14/2005WO2005033269A2 Methods for inducing an immune response via oral administration of an adenovirus
04/14/2005WO2005033268A2 Stem cells for clinical and commercial uses
04/14/2005WO2005033267A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof
04/14/2005WO2005033265A2 Optimized multi-epitope constructs and uses thereof
04/14/2005WO2005032475A2 In vivo efficacy of ny-eso-1 plus adjuvant
04/14/2005WO2005012494A3 Treatment of organ transplant rejection
04/14/2005WO2005012485A3 Methods for treating diabetes and related disorders using pde10a inhibitors
04/14/2005WO2005010147A3 Device and method for contacting pocoliter volumes of fluids
04/14/2005WO2005003322A3 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts
04/14/2005WO2005003315A3 Compositions and methods for peptide-assisted transfection
04/14/2005WO2005001040A3 Non-lethal conditioning methods for conditioning a recipient for bone marrow transplantation
04/14/2005WO2004111190A3 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES
04/14/2005WO2004108890A3 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms
04/14/2005WO2004101739A3 Methods for chemically synthesizing immunoglobulin chimeric proteins
04/14/2005WO2004096990A3 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
04/14/2005WO2004096989A3 Single chain antigen-binding polypeptides for polymer conjugation
04/14/2005WO2004087884A3 TARGETING ENZYMES OF THE tRNA SPLICING PATHWAY FOR IDENTIFICATION OF ANTI-FUNGAL AND/OR ANTI-PROLIFERATIVE MOLECULES
04/14/2005WO2004087865A3 The preparation and application of ligand-biopolymer conjugates
04/14/2005WO2004083378A3 Mammalian cell lines specifically deficient in o-linked glycosylation
04/14/2005WO2004078930A3 Nanometer-controlled polymeric thin films that resist adsorption of biological molecules and cells
04/14/2005WO2004070019A3 Membrane active polymers
04/14/2005WO2004070013A3 Use of islet 1 as a marker for isolating or generating stem cells
04/14/2005WO2004044140A3 2’-substituted oligomeric compounds and compositions for use in gene modulations
04/14/2005WO2004022714A3 Organic species that facilitate charge transfer to or from nanostructures
04/14/2005WO2003027228A3 Receptors and membrane-associated proteins
04/14/2005US20050080032 Modulating expression of an endogenous marine invertebrate gene or an endogenous gene in a pathogen that infects marine invertebrate by administering to invertebrate at least one dsRNA that comprises a sequence having substantial sequence homology to the endogenous pathogen gene
04/14/2005US20050079598 Semiconductor substrate for use chip to chip and/or chip to standard genomic/gene expression analysis
04/14/2005US20050079578 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease
04/14/2005US20050079560 Detection and treatment of cancers of the colon
04/14/2005US20050079487 Liquid crystals with reduced toxicity and applications thereof
04/14/2005CA2545248A1 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
04/14/2005CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides
04/14/2005CA2540857A1 Gene modulation by rb2/p130 expression
04/14/2005CA2540854A1 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
04/14/2005CA2540764A1 In vivo efficacy of ny-eso-1 plus adjuvant
04/14/2005CA2540681A1 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders
04/14/2005CA2540667A1 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
04/14/2005CA2540253A1 Hiv-dependent expression constructs and uses therefor
04/14/2005CA2526425A1 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof
04/13/2005EP1522037A2 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
04/12/2005US6878538 Multichannel electroporation device with reduced frictional resistance for high throughput introduction of exogenous molecules into cells
04/12/2005CA2267994C Truncated platelet-activating factor acetylhydrolase
04/07/2005WO2005030934A2 Methods of preventing restenosis
04/07/2005WO2005030933A2 Bone morphogenetic protein (bmp)-7 based diagnosis and treatment of cancer
04/07/2005WO2005030932A2 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage
04/07/2005WO2005030931A2 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
04/07/2005WO2005030930A2 Variants of cyan fluorescent protein with improved fluorescent properties
04/07/2005WO2005030929A2 Polymeric nucleic acid hybridization probes
04/07/2005WO2005030928A2 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
04/07/2005WO2005030927A2 Methods and compositions for in vivo inflammation monitoring
04/07/2005WO2005030925A2 Microfluidic rotary flow reactor matrix
04/07/2005WO2005030924A2 Genetic markers for skatole metabolism
04/07/2005WO2005019413A3 A low maintenance detector for biological agents
04/07/2005WO2005010168A3 Method and system for detecting chloramphenicol
04/07/2005WO2005010157A3 Use of pleiotrophin in the diagnosis, treatment and prevention of disease
04/07/2005WO2005005601A8 Compositions and methods for treating and diagnosing cancer
04/07/2005WO2004096988A3 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance
04/07/2005WO2004096976A3 Spex compositions and methods of use
04/07/2005WO2004094600A3 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
04/07/2005WO2004083405A3 Separation and accumulation of subcellular components, and proteins derived therefrom
04/07/2005WO2004078919A3 Superactive cellulase formulation using cellobiohydrolase-1 from penicillium funiculosum
04/07/2005WO2004074446A3 Parkin interacting polypeptides and methods of use
04/07/2005WO2004070009A3 Targeted multivalent macromolecules
04/07/2005WO2004063338A3 Methos for analyzing global regulation of coding and non-coding rna transcripts involving low molecular weight rnas
04/07/2005WO2004043978A3 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
04/07/2005US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics
04/07/2005US20050075308 Methods and compositions for producing antigenic responses
04/07/2005US20050075307 Modulation of aminopeptidase N expression
04/07/2005US20050074838 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
04/07/2005US20050074823 Monoclonal antibody for use in treatment and prevention of pathogen infection
04/07/2005CA2539947A1 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage
04/07/2005CA2539432A1 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
04/07/2005CA2525217A1 Genetic markers for skatole metabolism
04/06/2005EP1520032A2 Lung cancer therapeutics and diagnostics
03/2005
03/31/2005WO2005029280A2 Performing sequence analysis as a multipart plan storing intermediate results as a relation
03/31/2005WO2005029041A2 High density sequence detection methods and apparatus
03/31/2005WO2005028635A2 Microfluidic differential extraction cartridge
03/31/2005WO2005028634A2 Improved mva vaccines
03/31/2005WO2005028633A2 Modulation of rankl expression
03/31/2005WO2005028632A2 Hyaluronan (ha) esterification via acylation technique for moldable devices
03/31/2005WO2005028631A2 A novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same
03/31/2005WO2005028630A2 Engineered zinc finger proteins for regulation of gene expression
03/31/2005WO2005028629A2 Whole genome expression analysis system
03/31/2005WO2005028627A2 Performing sequence analysis as a relational join
03/31/2005WO2005028626A2 Cell culture media
03/31/2005WO2005028625A2 Consensus/ancestral immunogens
03/31/2005WO2005028624A2 Molecular scaffolds for kinase ligand development
03/31/2005WO2005028623A2 Broad host range pbbr1-based plasmid mutant derivatives having altered plasmid copy number
03/31/2005WO2005028621A2 Assays with primary cells
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 100